PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

FLORHAM PARK, N.J., May 18, 2022 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and... | May 18, 2022

Related Keywords

United States ,Massachusetts ,Sanjay Zaveri ,Strongbridge Biopharma ,Frank Bedu ,Xeris Pharmaceuticals ,Twitter ,Carlson School Of Management ,Biotechnology Corporation ,Massachusetts College Of Pharmacy ,Biotechnology Corporation The Company ,Master Of Business Administration ,United States Securities Exchange ,University Of Minnesota ,Biotechnology Corporation Nasdaq ,Head Of Business Development ,Business Development ,Globenewswire Inc ,Senior Vice President ,Corporate Strategy ,Before Strongbridge ,Business Administration ,Chief Executive Officer ,Nasdaq Listing Rule ,United States Securities Exchange Act ,United States Securities Act ,Pds Biotechnology Corporation Stock Exchange ,News ,Information ,Press Release ,Florham ,Bay ,022 ,Ads ,Biotechnology ,Corporation ,Immunotherapy ,Company ,Developing ,Rowing ,Pipeline ,F ,Molecularly ,Argeted ,Dancer ,Mmunotherapies Pdsb Us70465t1079 ,